methandrostenolone has been researched along with phenformin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bielawiec, M; Myśliwiec, M; Perzanowski, A | 1 |
| Bielawiec, M; Bodzenta, A; Czestochowska, E; Dabrowski, S; Kiersnowska-Rogowska, B; Kłoczko, J; Lukjan, H; Myśliwiec, M; Tymiński, W | 1 |
1 trial(s) available for methandrostenolone and phenformin
| Article | Year |
|---|---|
Clinical investigations on long-term activation of fibrinolysis by anabolic steroids.
Topics: Adult; Aged; Arteriosclerosis Obliterans; Clinical Trials as Topic; Coronary Disease; Female; Fibrinolysis; Humans; Male; Methandrostenolone; Middle Aged; Myocardial Infarction; Phenformin; Stanozolol; Thrombophlebitis; Varicose Veins | 1986 |
1 other study(ies) available for methandrostenolone and phenformin
| Article | Year |
|---|---|
The influence of long-term therapy with phenformin plus metanabol on blood fibrinolytic activity, platelet adhesiveness and lipid metabolism in patients with arteriosclerosis.
Topics: Adult; Aged; Arteriosclerosis; Fibrinolytic Agents; Humans; Lipid Metabolism; Long-Term Care; Male; Methandrostenolone; Middle Aged; Phenformin; Platelet Adhesiveness | 1976 |